1.5 Mg Rasburicase

Name: 1.5 Mg Rasburicase
Brand: NEETCO BIOPHARMA
Price: 4999 INR
Availability: InStock

Price 4999 INR/ Vial

Get a Price/Quote

MOQ : 1 Vial

1.5 Mg Rasburicase Specification

Dosage Form
Lyophilized Powder for Injection

Indication
Prevention and treatment of hyperuricemia in pediatric and adult patients with malignancy receiving chemotherapy

Salt Composition
Rasburicase 1.5 mg

Enzyme Types
Uricase (Recombinant) Enzyme

Feature
Recombinant urate-oxidase for rapid uric acid reduction

Ingredients
Rasburicase, Excipients (as per formulation), Sterile water for injection as solvent

Application
Medical/Pharmaceutical Use in Tumor Lysis Syndrome

Ph Level
7.0 to 8.0 (after reconstitution)

Temperature Needed For Fermentation
25-30C (Fermentation during Biotech Production)

Physical Color/Texture
White to Off-white Lyophilized Powder

Fermentation Smell
Odorless

Enzymatic Activity
Not less than 1.6 U/mg

Storage Instructions
Store at 2C to 8C (Refrigerated, Do Not Freeze)

Shelf Life
24 months from date of manufacture

Packaging Type
Vial with accompanying solvent ampoule

Molecular Weight
Approximately 34 kDa

Contraindications
History of G6PD deficiency, hypersensitivity to rasburicase

Brand Name
As per packaging (generic Rasburicase 1.5mg)

Usage Precautions
Monitor for allergic reactions, hemolysis in G6PD-deficient patients

Reconstitution Instructions
Dissolve vial in supplied solvent prior to intravenous administration

Pack Size
Single-use vial containing 1.5 mg Rasburicase

Route of Administration
Intravenous Injection

About 1.5 Mg Rasburicase

Explore the unparalleled efficacy of this 1.5 mg Rasburicase, a pivotal solution for rapid reduction of uric acid levels in tumor lysis syndrome. Each pristine, single-use vial contains lyophilized powder, ready to be reconstituted with the included sterile water, ensuring optimal intravenous administration. Favorable reviews have highlighted its recombinant uricase, providing swift results in pediatric and adult oncology settings. Personalise your order and Add to Cart now for precise pharmaceutical applications. Observe contraindications related to G6PD deficiency and hypersensitivity. Consult the branded packaging for full details.

Advanced Application and Clinical Usage

Rasburicase 1.5 mg is vital for healthcare providers treating hyperuricemia associated with malignancy in patients receiving chemotherapy. Its unique recombinant uricase enzyme offers unparalleled speed and efficacy, making it pivotal during tumor lysis syndrome management. Used by oncologists in hospitals and clinics, its pristine white to off-white lyophilized powder form is easy to reconstitute and administer intravenously. It stands out for consistent enzymatic activity, optimal pH, and reliable results across pediatric and adult cases.

Export Excellence and Order Fulfillment

Shipped globally from India, this Rasburicase variant finds main export markets across Asia, Europe, and Middle Eastern countries. Packaging includes a securely sealed vial and solvent ampoule, ensuring safe drop-off and handover. Express shipping options guarantee product integrity and timely delivery. Payment terms are flexible, supporting wire transfer and verified channels. Each pack meets international pharmaceutical standards, with detailed labeling for easy tracking and handling throughout the export process.

FAQ's of 1.5 Mg Rasburicase:

Q: How do I properly reconstitute and administer Rasburicase 1.5 mg?

A: To reconstitute, gently dissolve the lyophilized powder in the supplied sterile water ampoule as per instructions. The solution is administered intravenously under medical supervision, ensuring proper dosage and monitoring for reactions.

Q: What is Rasburicase 1.5 mg mainly used for?

A: This product is primarily used for the prevention and treatment of hyperuricemia occurring in pediatric and adult patients with malignancies undergoing chemotherapy-especially during tumor lysis syndrome.

Q: When should Rasburicase not be administered?

A: Rasburicase is contraindicated in individuals with G6PD deficiency or hypersensitivity to the enzyme or its excipients. Always consult a healthcare provider to assess patient suitability and risk factors before use.

Q: Where can I find the instructions for storage and handling?

A: Storage instructions are available on the packaging and product insert. The vial must be refrigerated at 2-8C and should never be frozen. Proper handling is essential to maintain its efficacy and safety profile during transport and storage.

Q: What are the payment and shipping options available for export orders?

A: Export orders support express shipping with secure drop-off and handover. Payment terms include wire transfers and trusted international payment channels, ensuring safe and prompt delivery to your location.

Q: How does Rasburicase benefit oncology patients?

A: Rasburicase provides rapid reduction of serum uric acid levels, minimizing kidney complications during tumor lysis syndrome. Its recombinant uricase mechanism is pivotal in protecting renal function in patients with high cell turnover due to chemotherapy.

Tell us about your requirement